From the Editor-in-Chief

Molecular profiling that has led to spectacular advances in cancer treatment may also improve cancer survivorship.

by William G. Nelson, MD, PhD

Forward Look

Surgical oncologist Samilia Obeng-Gyasi describes research that shows chronic stress is associated with higher mortality in cancer.

by Ashley P. Taylor

Forward Look

A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.

by Darcy Lewis

Forward Look

Study supports the use of immune checkpoint inhibitors in an understudied population.

by Carolyn Bernhardt

Researchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and pain in the hands and feet.

by Cameron Walker

Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.

by Erin O’Donnell

Facts and Stats

Between 2020 and 2050, cancer is expected to cost the global economy $25 trillion.

by Thomas Celona

Speakers at SABCS discuss measuring and meeting social factors that affect the health and outcomes of breast cancer patients.

by Kevin McLaughlin

PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.

by Sandra Gordon

Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.

by Myles Starr